Celmatix Partners With Onctotest-Teva to Offer Reproductive Health Genetic Test in Israel

Oct 09, 2018

|

NEW YORK (GenomeWeb) – Celmatix said today that it has partnered with Oncotest-Teva, a subsidiary of Teva Pharmaceutical Industries, to make Celmatix's Fertilome genetic test for reproductive health and fertility available in Israel.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Celmatix Partners With Onctotest-Teva to Offer Reproductive Health Genetic Test in Israel

To read the full story....

Breaking News

Hologic Fiscal Q1 Revenues Rise 89 Percent as Dx Testing Demand Surges

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

What's Popular?

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Roche Renews Agreement to Distribute Sysmex Hematology Products

Abbott Continuing Focus on Rapid Testing in Light of COVID-19 Pandemic

Sponsorships